Mitochondrial molecular genetics and human disease

Eric A Shoubridge,Antoni Barrientos
DOI: https://doi.org/10.1093/hmg/ddae049
IF: 5.1214
2024-05-25
Human Molecular Genetics
Abstract:The human mitochondrial genome (mtDNA) was sequenced in 1981 long before advances that made sequencing of the entire human genome possible, the first draft of which was released about 20 years later. Although mtDNA makes up only a small percentage of the total cellular DNA, it has assumed outsized importance because of its implication in human diseases, as well as its role in priming the innate immune response and in inflammation. Human mtDNA codes for only 37 genes that express a handful of polypeptides, all essential subunits of the oxidative phosphorylation complexes, and the rRNAs and tRNAs necessary for their synthesis on dedicated mitochondrial ribosomes. MtDNA relies on the expression of hundreds of nucleus-encoded genes for its maintenance, replication, repair, transcription, and translation. Consequently, the expression of the nuclear and mitochondrial genomes requires exquisite coordination. Hundreds of mutations in mtDNA and the nuclear genes necessary for its expression have now been identified in a strikingly diverse array of human disease phenotypes. The reviews gathered in this special issue address recent developments in our understanding of the molecular genetics of mtDNA expression, mitochondrial disease pathogenesis, the role of mtDNA in innate immunity, and the emerging tools for mtDNA editing.
genetics & heredity,biochemistry & molecular biology
What problem does this paper attempt to address?